There is evidence that BRCA1-related breast cancers have a distinct profile on microarray analysis (van't Veer et al, 2002) and that these cancers have a distinctive spectrum of TP53 mutations (Greenblatt et al, 2001). The gene discussed is TP53; the disease is cancer.